Aurora Cannabis, Inc. (NYSE: ACB) reported a wider loss for the fourth quarter of 2020, hurt by a 5% decrease in revenues. The company’s stock fell sharply during Tuesday’s after-hours trading session soon after the announcement.
The Canada-based medical marijuana company said its loss from continuing operations widened to C$1.86 billion in the fourth quarter from C$136.13 million in the third quarter. The deterioration in the bottom-line performance reflects a 5% decrease in revenues to C$72.1 million.
Shares of Aurora Cannabis closed Tuesday’s regular session higher in the New York Stock Exchange but decreased during the extended trading session. The stock, which has been on a losing streak for several months, has lost about 70% so far this year.
Most Popular
ADBE Earnings: Adobe Q1 2024 revenue and profit beat estimates
Design software maker Adobe Inc. (NASDAQ: ADBE) on Thursday reported an increase in first-quarter 2024 revenue and earnings. The results also surpassed analysts' forecasts. First-quarter revenues came in at $5.18
Earnings Preview: FedEx (FDX) likely to report higher revenue and profit for Q3
FedEx Corporation (NYSE: FDX) delivered positive earnings performance and margin expansion in the first half of fiscal 2024, despite lower revenues. The cargo giant has been on a path of
Key takeaways from Dollar General’s (DG) Q4 2023 earnings report
Shares of Dollar General Corporation (NYSE: DG) fell over 4% on Thursday despite the company delivering better-than-expected earnings results for the fourth quarter of 2023. The top and bottom line numbers